BRUKER CORPORATION Interest Expense
BRUKER CORPORATION (BRKR) reported Interest Expense of $15.70 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-09.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-08-09
- BRUKER CORPORATION interest expense for the quarter ending 2024-06-30 was $15.70M, a 302.56% increase year-over-year.
- BRUKER CORPORATION interest expense for the quarter ending 2024-03-31 was $5.00M, a 19.05% increase year-over-year.
- BRUKER CORPORATION interest expense for the quarter ending 2023-12-31 was $4.40M, a 2.33% increase year-over-year.
- BRUKER CORPORATION interest expense for the quarter ending 2023-09-30 was $3.90M, a 5.41% increase year-over-year.
- BRUKER CORPORATION interest expense for fiscal 2023 was $16.40M, a 1.86% increase from fiscal 2022.
- BRUKER CORPORATION interest expense for fiscal 2022 was $16.10M, a 12.59% increase from fiscal 2021.
- BRUKER CORPORATION interest expense for fiscal 2021 was $14.30M, a 0.69% decline from fiscal 2020.
- BRUKER CORPORATION interest expense for fiscal 2020 was $14.40M, a 10.00% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2024-06-30 | $15.70M 10-Q · filed 2024-08-09 | $20.70M 10-Q · filed 2024-08-09 | $25.10M derived: sum of 3 quarters · filed 2024-08-09 | $29.00M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2024-03-31 | $5.00M 10-Q · filed 2024-05-10 | $9.40M derived: sum of 2 quarters · filed 2024-05-10 | $13.30M derived: sum of 3 quarters · filed 2024-05-10 | $17.20M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-12-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $8.30M derived: sum of 2 quarters · filed 2024-02-29 | $12.20M derived: sum of 3 quarters · filed 2024-08-09 | $16.40M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $3.90M 10-Q · filed 2023-11-09 | $7.80M derived: sum of 2 quarters · filed 2024-08-09 | $12.00M 10-Q · filed 2023-11-09 | $16.30M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-06-30 | $3.90M 10-Q · filed 2024-08-09 | -$3.90M 10-Q · filed 2023-08-09 | $8.10M 10-Q · filed 2024-08-09 | -$8.10M 10-Q · filed 2023-08-09 | $12.40M derived: sum of 3 quarters · filed 2024-08-09 | $16.10M derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $4.20M 10-Q · filed 2024-05-10 | $8.50M derived: sum of 2 quarters · filed 2024-05-10 | $12.20M derived: sum of 3 quarters · filed 2024-05-10 | $8.20M derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $8.00M derived: sum of 2 quarters · filed 2024-02-29 | $4.00M derived: sum of 3 quarters · filed 2024-02-29 | $16.10M 10-K · filed 2024-02-29 | |||
| 2022-09-30 | $3.70M 10-Q · filed 2023-11-09 | -$300.00K derived: sum of 2 quarters · filed 2023-11-09 | $11.80M 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | -$4.00M 10-Q · filed 2023-08-09 | -$8.10M 10-Q · filed 2023-08-09 | |||||
| 2022-03-31 | $4.10M 10-Q · filed 2023-05-10 | ||||||
| 2021-12-31 | $14.30M 10-K · filed 2024-02-29 | ||||||
| 2020-12-31 | $14.40M 10-K · filed 2023-03-01 | ||||||
| 2019-12-31 | $16.00M 10-K · filed 2022-02-28 | ||||||
| 2018-12-31 | $12.60M 10-K · filed 2021-03-01 | ||||||
| 2017-12-31 | $15.40M 10-K · filed 2020-03-27 | ||||||
| 2016-12-31 | $13.20M 10-K · filed 2019-03-01 | ||||||
| 2015-12-31 | $13.00M 10-K · filed 2018-03-16 | ||||||
| 2014-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $7.20M derived: sum of 2 quarters · filed 2017-03-01 | $10.30M derived: sum of 3 quarters · filed 2017-03-01 | $13.30M 10-K · filed 2017-03-01 | |||
| 2014-09-30 | $3.20M 10-Q · filed 2014-11-07 | $6.30M derived: sum of 2 quarters · filed 2014-11-07 | $9.30M 10-Q · filed 2014-11-07 | $13.30M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $3.10M 10-Q · filed 2014-08-08 | $6.10M 10-Q · filed 2014-08-08 | $10.10M derived: sum of 3 quarters · filed 2016-02-29 | $13.30M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $3.00M 10-Q · filed 2014-05-09 | $7.00M derived: sum of 2 quarters · filed 2016-02-29 | $10.20M derived: sum of 3 quarters · filed 2016-02-29 | $13.30M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $7.20M derived: sum of 2 quarters · filed 2016-02-29 | $10.30M derived: sum of 3 quarters · filed 2016-02-29 | $13.40M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | $3.20M 10-Q · filed 2014-11-07 | $6.30M derived: sum of 2 quarters · filed 2014-11-07 | $9.40M 10-Q · filed 2014-11-07 | $13.50M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-06-30 | $3.10M 10-Q · filed 2014-08-08 | $6.20M 10-Q · filed 2014-08-08 | $10.30M derived: sum of 3 quarters · filed 2015-02-27 | $13.70M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-03-31 | $3.10M 10-Q · filed 2014-05-09 | $7.20M derived: sum of 2 quarters · filed 2015-02-27 | $10.60M derived: sum of 3 quarters · filed 2015-02-27 | $14.10M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $7.50M derived: sum of 2 quarters · filed 2015-02-27 | $11.00M derived: sum of 3 quarters · filed 2015-02-27 | $14.30M 10-K · filed 2015-02-27 | |||
| 2012-09-30 | $3.40M 10-Q · filed 2013-11-08 | $3.60M 10-Q · filed 2012-11-08 | $6.90M derived: sum of 2 quarters · filed 2013-11-08 | $10.20M 10-Q · filed 2013-11-08 | $10.70M 10-Q · filed 2012-11-08 | $12.70M derived: sum of 4 quarters · filed 2014-02-27 | |
| 2012-06-30 | $3.50M 10-Q · filed 2013-08-08 | $3.60M 10-Q · filed 2012-08-09 | $6.80M 10-Q · filed 2013-08-08 | $7.10M 10-Q · filed 2012-08-09 | $9.30M derived: sum of 3 quarters · filed 2014-02-27 | $11.00M derived: sum of 4 quarters · filed 2014-02-27 | |
| 2012-03-31 | $3.30M 10-Q · filed 2013-05-09 | $3.50M 10-Q · filed 2012-05-09 | $5.80M derived: sum of 2 quarters · filed 2014-02-27 | $7.50M derived: sum of 3 quarters · filed 2014-02-27 | $9.10M derived: sum of 4 quarters · filed 2014-02-27 | ||
| 2011-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $4.20M derived: sum of 2 quarters · filed 2014-02-27 | $5.80M derived: sum of 3 quarters · filed 2014-02-27 | $7.30M 10-K · filed 2014-02-27 | |||
| 2011-09-30 | $1.70M 10-Q · filed 2012-11-08 | $3.30M derived: sum of 2 quarters · filed 2012-11-08 | $4.80M 10-Q · filed 2012-11-08 | $6.40M derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2011-06-30 | $1.60M 10-Q · filed 2012-08-09 | $3.10M 10-Q · filed 2012-08-09 | $4.70M derived: sum of 3 quarters · filed 2013-02-28 | $5.90M derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2011-03-31 | $1.50M 10-Q · filed 2012-05-09 | $3.10M derived: sum of 2 quarters · filed 2013-02-28 | $4.30M derived: sum of 3 quarters · filed 2013-02-28 | $5.60M derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2010-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $2.80M derived: sum of 2 quarters · filed 2013-02-28 | $4.10M derived: sum of 3 quarters · filed 2013-02-28 | $5.60M 10-K · filed 2013-02-28 | |||
| 2010-09-30 | $1.20M 10-Q · filed 2011-11-09 | $2.50M derived: sum of 2 quarters · filed 2011-11-09 | $4.00M 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | $1.30M 10-Q · filed 2011-08-09 | $2.80M 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | $7.50M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |